OTCA16 Bioresorbable Stents in cardiovascular indications (coronary artery disease) Project Plan Now Available
The final project plan of the assessment on “Bioresorbable Stents in cardiovascular indications (coronary artery disease)” and the comments provided by the external experts and the manufacturers are now available. OTCA16 Project Plan HERE OTCA16 External Expert and Manufacturer Comments HERE
The Joint Assessment, OTJA08, on “Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin” is now available.
We are pleased to announce that the joint rapid assessment on “Continuous glucose monitoring (CGM real-time) and flash glucose monitoring (FGM) as personal, standalone systems in patients with diabetes mellitus treated with insulin” is available. The health technologies assessed include rtCGM
OTJA10 “Stool DNA testing for early detection of colorectal cancer” Final Project Plan Now Available
[vc_row][vc_column][vc_column_text]This is the final project plan of the assessment on Stool DNA testing for early detection of colorectal cancer. Download Final Project Plan HERE Download summary of comments received from external review, including the authors’ answers HERE [pdf-embedder url="https://www.eunethta.eu/wp-content/uploads/2018/07/OTJA10_Project-Plan__final.pdf" title="OTJA10_Project Plan__final"][/vc_column_text][/vc_column][/vc_row]
This is the final project plan of the assessment on robotic surgery in thoracic and visceral indications. Download HERE [pdf-embedder url="https://www.eunethta.eu/wp-content/uploads/2018/07/Project-Plan_OTCA14.pdf" title="Project Plan_OTCA14"]
Patient group input requested for a new Joint Assessment on a medicinal product for Diabetes Type 1 – Closing August 3
EUnetHTA Joint Production is pleased to announce the launch of the REA for Sotagliflozin for Type 1 diabetes mellitus (PTJA04) For this specific assessment on a medicinal product for Diabetes Type 1, an ‘open call for patient group submission‘ is used.
Materials now available from 1st EUnetHTA Workshop on HTA and MDR/IVDR (from 29th May 2018, Vienna) and 2nd Workshop Announced (28 May, 2019, Vienna)
We are happy to announce that the documentation of the 1st EUnetHTA Workshop on HTA and MDR/IVDR (from 29th May 2018, Vienna) is now available. Please note that the 2nd EUnetHTA Workshop will take place on TUE 28th May 2019
September 3, 2018 – Real-World Evidence in Medicine Development – An online introductory course – call for registration
Real-World Evidence in Medicine Development An online introductory course Under the supervision of leading academics involved in the IMI GetReal project, this interactive online course will give an understanding of current techniques, opportunities and challenges for the use of real-world evidence in
Following on the successful launch of the JA3 procedures for European Network for Health Technology Assessment (EUnetHTA) Early Dialogues (ED) for Pharmaceutical products, EUnetHTA is pleased to announce the future launch of EDs for Medical Devices. The procedure is a single
[vc_row][vc_column][vc_column_text]The first National Implementation report has now been published. The report follows up the first five EUnetHTA assessments to be published. For these assessments, 46 examples of use have been reported, including both use to support assessment procedures and use as